Springhill Fund Asset Management (Hk) CO LTD Portfolio Holdings
Springhill Fund Asset Management (Hk) CO LTD
- $20.9 Billion
- Q1 2025
Springhill Fund Asset Management (Hk) CO LTD has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $20.9 Billion distributed in 19 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $4.03B, Summit Therapeutics Inc. with a value of $2.4B, Janux Therapeutics, Inc. with a value of $2.12B, Regeneron Pharmaceuticals, Inc. with a value of $1.65B, and Neurocrine Biosciences Inc with a value of $1.51B.
Examining the 13F form we can see an decrease of $40.7B in the current position value, from $61.6B to 20.9B.
Springhill Fund Asset Management (Hk) CO LTD is based out at Hong Kong, K3
Below you can find more details about Springhill Fund Asset Management (Hk) CO LTD portfolio as well as his latest detailed transactions.